Location: East Brunswick NJ, Myrtle Beach SC, Grand Rapids MI,
Sponsor: Flare Therapeutics Inc.
Sex: Male
Age: 18+
Code: NCT07719361
Phase1, Recruiting
Active & ResponsiveNew
Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.
for
Reccurent/Metastatic Solid Tumor Disease,
Location: Quebec
Sponsor: CHU de Quebec-Universite Laval
Sex: Male
Age: 18+
Code: NCT07483658
Recruiting
Active & Responsive
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans Affairs
for
Lung Cancer Diagnosis, Colorectal Cancer (Diagnosis),
Location: Jamaica NY, New York NY, Brooklyn NY, Staten Island NY
Sponsor: NYU Langone Health
Sex: All
Age: 18+
Code: NCT06559059
Recruiting
Active & Responsive
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
for
Prostate Cancer
Location: New York NY
Sponsor: SpectraCure AB
Sex: Male
Age: 18+
Code: NCT06807359
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
for
Castration-Resistant Prostate Carcinoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: Male
Age: 0+
Code: NCT06145633
Phase2, Recruiting
Active & Responsive
PET/CT Characterization of Treatment Resistance
for
Prostate Cancer
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: Male
Age: 18+
Code: NCT05647564
Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors
for
Cancer, Colorectal Cancer, Solid Tumor,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Parabilis Medicines, Inc.
Sex: All
Age: 18+
Code: NCT05919264
Phase1, Phase2, Recruiting
Active & Responsive
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
for
Metastatic Castrate Resistant Prostate Cancer,
Location: New York NY, Philadelphia PA, Washington D.C. DC,